Abeona Therapeutics (ABEO) Non-Current Debt (2018 - 2025)
Historic Non-Current Debt for Abeona Therapeutics (ABEO) over the last 7 years, with Q3 2025 value amounting to $10.9 million.
- Abeona Therapeutics' Non-Current Debt fell 2353.93% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year decrease of 2353.93%. This contributed to the annual value of $13.0 million for FY2024, which is N/A changed from last year.
- Abeona Therapeutics' Non-Current Debt amounted to $10.9 million in Q3 2025, which was down 2353.93% from $14.0 million recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Non-Current Debt registered a high of $18.1 million during Q1 2024, and its lowest value of $1.2 million during Q1 2021.
- In the last 4 years, Abeona Therapeutics' Non-Current Debt had a median value of $9.6 million in 2021 and averaged $9.1 million.
- Within the past 5 years, the most significant YoY rise in Abeona Therapeutics' Non-Current Debt was 22415.22% (2022), while the steepest drop was 5138.76% (2022).
- Quarter analysis of 4 years shows Abeona Therapeutics' Non-Current Debt stood at $3.8 million in 2021, then increased by 8.75% to $4.2 million in 2022, then surged by 213.16% to $13.0 million in 2024, then decreased by 16.68% to $10.9 million in 2025.
- Its Non-Current Debt was $10.9 million in Q3 2025, compared to $14.0 million in Q2 2025 and $11.1 million in Q1 2025.